Oncology Therapeutics / NCI
Verified Pharmaceutical Manufacturer & Oncology Drug Supplier
Oncology Therapeutics / NCI
Verified PartnerRegistered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.
Company Profile & Registration
Legal Organization NameOncology Therapeutics / NCI
Manufacturer Identification CodeRegistered
Authorized RepresentativeCorporate Representative
Compliance & StatusActive / Listed
Oncology Drugs & Clinical Formulations
Featured Drug Formulation
View Complete Drug Profile Abiraterone Acetate
Generic: Abiraterone Acetate
Class: CYP17 Inhibitor / Androgen Biosynthesis Inhibitor
Indications: Metastatic Castration-Resistant Prostate Cancer (mCRPC) and High-Risk Castration-Sensitive Prostate Cancer in combination with prednisone.
Direct Communication & Assistance
Send an Inquiry to Oncology Therapeutics / NCI
Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.
